Woodline Partners LP Cytokinetics Inc Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Woodline Partners LP holds 129,035 shares of CYTK stock, worth $6.38 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
129,035
Previous 198,181
34.89%
Holding current value
$6.38 Million
Previous $10.7 Million
36.55%
% of portfolio
0.06%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$726 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$582 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$479 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$385 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$319 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.66B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...